Notice of Change to Application and Submission Information for RFA-NS-23-026 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
Notice Number:
NOT-NS-23-086

Key Dates

Release Date:

May 24, 2023

Related Announcements

  • April 17, 2023 - BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) - See NOFO RFA-NS-23-026. 
  • February 15, 2019 - Update to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials - See Notice NOT-OD-19-083

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of a change to the Application and Submission Information - Post Submission Materials allowed for RFA-NS-23-026 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)". This notice of funding opportunity (NOFO) has been modified to allow one-page of preliminary data as a post-submission material. This notice is effective for the June 14, 2023 due date and subsequent due dates. Changes to the NOFO are shown below.

 Currently Reads:

Section IV. Application and Submission Information

7. Other Submission Requirements and Information

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy

Modified to Read:

Section IV. Application and Submission Information

7. Other Submission Requirements and Information

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy. This NOFO will accept a one-page update with preliminary data as post-submission materials. 

The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting.

All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting.

All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Natalie Trzcinski, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: natalie.trzcinski@nih.gov